Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

This week in charts: ESMO’s winners and losers

The latest installment in BioPharma Dive’s visualization-focused series looks at Wall Street’s response to a trio of closely watched presentations at a top meeting for cancer drugs.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Friday 30 October →